Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gut microbiome and atrial fibrillation-results from a large population-based study.
Palmu J, Börschel CS, Ortega-Alonso A, Markó L, Inouye M, Jousilahti P, Salido RA, Sanders K, Brennan C, Humphrey GC, Sanders JG, Gutmann F, Linz D, Salomaa V, Havulinna AS, Forslund SK, Knight R, Lahti L, Niiranen T, Schnabel RB. Palmu J, et al. Among authors: ortega alonso a. EBioMedicine. 2023 May;91:104583. doi: 10.1016/j.ebiom.2023.104583. Epub 2023 Apr 27. EBioMedicine. 2023. PMID: 37119735 Free PMC article.
Rechallenge in idiosyncratic drug-induced liver injury: An analysis of cases in two large prospective registries according to existing definitions.
Pinazo-Bandera JM, Niu H, Alvarez-Alvarez I, Medina-Cáliz I, Del Campo-Herrera E, Ortega-Alonso A, Robles-Díaz M, Hernández N, Paraná R, Nunes V, Girala M, Bessone F, Lucena MI, Andrade RJ, García Cortés M. Pinazo-Bandera JM, et al. Among authors: ortega alonso a. Pharmacol Res. 2024 May;203:107183. doi: 10.1016/j.phrs.2024.107183. Epub 2024 Apr 15. Pharmacol Res. 2024. PMID: 38631619 Free article.
Hepatitis C virus point-of-care microelimination approach in a vulnerable population in the South of Spain.
Pinazo-Bandera JM, Aranda J, García-García AM, Alcántara R, Ortega-Alonso A, Del Campo-Herrera E, Clavijo E, García-Escaño MD, Ruiz Ruiz JJ, Morales-Herrera M, Valle-López V, Martín-Alarcón R, Viciana I, Jiménez JB, Fernández-García F, Toro-Ortiz JP, Sánchez-Yáñez E, Álvarez-Álvarez I, Andrade RJ, Robles-Díaz M, García-Cortés M. Pinazo-Bandera JM, et al. Among authors: ortega alonso a. Gastroenterol Rep (Oxf). 2024 Jan 22;12:goad077. doi: 10.1093/gastro/goad077. eCollection 2024. Gastroenterol Rep (Oxf). 2024. PMID: 38264764 Free PMC article.
Prior drug allergies are associated with worse outcome in patients with idiosyncratic drug-induced liver injury: A machine learning approach for risk stratification.
Niu H, Solis-Muñoz P, García-Cortés M, Sanabria-Cabrera J, Robles-Diaz M, Romero-Flores R, Bonilla-Toyos E, Ortega-Alonso A, Pinazo-Bandera JM, Cabello MR, Bessone F, Hernandez N, Lucena MI, Andrade RJ, Medina-Caliz I, Alvarez-Alvarez I. Niu H, et al. Among authors: ortega alonso a. Pharmacol Res. 2024 Jan;199:107030. doi: 10.1016/j.phrs.2023.107030. Epub 2023 Dec 8. Pharmacol Res. 2024. PMID: 38072217 Free article.
Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registries.
García-Cortés M, Ortega-Alonso A, Matilla-Cabello G, Medina-Cáliz I, Castiella A, Conde I, Bonilla-Toyos E, Pinazo-Bandera J, Hernández N, Tagle M, Nunes V, Parana R, Bessone F, Kaplowitz N, Lucena MI, Alvarez-Alvarez I, Robles-Díaz M, Andrade RJ. García-Cortés M, et al. Among authors: ortega alonso a. Liver Int. 2023 Aug;43(8):1749-1760. doi: 10.1111/liv.15623. Epub 2023 Jun 3. Liver Int. 2023. PMID: 37269163
Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damage.
Cueto-Sánchez A, Niu H, Álvarez-Álvarez I, López-Longarela B, Del Campo-Herrera E, Ortega-Alonso A, García-Cortés M, Pinazo-Bandera J, Sanabria-Cabrera J, Díaz-Mochón JJ, Lucena MI, Andrade RJ, Stephens C, Robles-Díaz M. Cueto-Sánchez A, et al. Among authors: ortega alonso a. Br J Clin Pharmacol. 2023 Aug;89(8):2497-2507. doi: 10.1111/bcp.15724. Epub 2023 Apr 10. Br J Clin Pharmacol. 2023. PMID: 36965054
Microbiota diversity in nonalcoholic fatty liver disease and in drug-induced liver injury.
Rodriguez-Diaz C, Taminiau B, García-García A, Cueto A, Robles-Díaz M, Ortega-Alonso A, Martín-Reyes F, Daube G, Sanabria-Cabrera J, Jimenez-Perez M, Isabel Lucena M, Andrade RJ, García-Fuentes E, García-Cortes M. Rodriguez-Diaz C, et al. Among authors: ortega alonso a. Pharmacol Res. 2022 Aug;182:106348. doi: 10.1016/j.phrs.2022.106348. Epub 2022 Jul 8. Pharmacol Res. 2022. PMID: 35817360 Free article.
Beneficial effect of ursodeoxycholic acid in patients with acyl-CoA oxidase 2 (ACOX2) deficiency-associated hypertransaminasemia.
Alonso-Peña M, Espinosa-Escudero R, Herraez E, Briz O, Cagigal ML, Gonzalez-Santiago JM, Ortega-Alonso A, Fernandez-Rodriguez C, Bujanda L, Calvo Sanchez M, D Avola D, Londoño MC, Diago M, Fernandez-Checa JC, Garcia-Ruiz C, Andrade RJ, Lammert F, Prieto J, Crespo J, Juamperez J, Diaz-Gonzalez A, Monte MJ, Marin JJG. Alonso-Peña M, et al. Among authors: ortega alonso a. Hepatology. 2022 Nov;76(5):1259-1274. doi: 10.1002/hep.32517. Epub 2022 Jul 1. Hepatology. 2022. PMID: 35395098 Free PMC article.
69 results